Datatrak International, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 13, 2021 at 10:01 am EDT
Share
DATATRAK International, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 1.603 million compared to USD 1.745 million a year ago. Operating loss was USD 390,137 compared to USD 38,457 a year ago. Net income was USD 501,459 compared to net loss of USD 40,672 a year ago. Basic earnings per share from continuing operations was USD 0.21 compared to basic loss per share from continuing operations of USD 0.02 a year ago. For the half year, sales was USD 3.274 million compared to USD 3.696 million a year ago. Operating loss was USD 500,021 compared to operating Income of USD 23,296 a year ago. Net income was USD 512,682 compared to USD 24,868 a year ago. Basic earnings per share from continuing operations was USD 0.21 compared to USD 0.01 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
